standard]
MSSSGPLSPNSSPSGSAVPPASSNDSTPPSESNPNQTTDSPPPPPPSASS
APPPQSSPPPDPSAPPPSPPQASPPEGSPPPPPPPSPPSSPPSPTPPSSP
PSPPPSPPPSSPPSSPPFPPAPPPNTNSPPPPTGSSPPPTLPPPPTSQGS
PPKESPAAPLAPPPPPPAISPSPPPPDLSPPTSSPPPPHPPKHSHPPPAL
PPTPISSPPIPPTSSPPPPSTAPPPPVPSPPFLYPPLPSNNASTNGSLPA
SPLPSRSTEKPTARSTQSNITSEATSRNSGGLKAGGVAAVVSVVGFLALT
LVVLAVWFTHKRKKRRNKFTLNYTRTSPFASSQNSDSSFLRSQFSSQLAG
SASANNYIYSPDGGIGASRSWFTYPELSAATNGFSANNILGEGGFGCVYK
GVLVDGREVAVKQLKDGGGQGEREFRAEVEIISRIHHRHLVSLVGYCISE
KQRLLVYDYVPNNTLHYHLHGEAKTVMDWASRVKVAAGAARGLAYLHEDC
QPRIIHRDIKSTNILLDNNFEARVADFGLAKLALELDLHTHVSTRVMGTF
GYLAPEYASTGKLTEKSDVFSFGVVLLELITGRKPVDSSQPLGDESLVEW
ARPLLTQALEKEDFGDLVDPKLGSNFVPNEMFRMIEAAAACVVRALDSMD
ELADLNNGVKPGQSGIFSSREHSAQIRMFQRMAFGSQDYSSDYFNSQSSL
RS
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR008271; Serine/threonine-protein kinase, active site IPR017441; Protein kinase, ATP binding site IPR017 |